Medicine of the future: how artificial intelligence is introduced into the surgery of the BSMU Clinic

Oncology in Russia is reaching a new level: an innovative development was presented at Sechenov University - the Sechenov.AI nephro neural network, capable of finding malignant tumors and helping doctors remove them. Such operations are already done on the kidneys, and in the future they will be able to remove neoplasms from any organs.

The project has already been implemented in the Clinic of the Bashkir State Medical University. More than 100 operations using neural networks have been successfully carried out. A fundamentally important difference from Western analogues is free access for all surgeons in Russia.

"The uniqueness of this product is that it is absolutely free. Any clinic, any surgeon in the Russian Federation can use it. In a day, in two, we are already discharging patients home," said Valentin Pavlov, rector of BSMU, academician of the Russian Academy of Sciences, chief freelance urologist of the Volga Federal District.

With accurate, verified movements, the oncourologist uses a robot to cut through the path to the tumor. In addition, artificial intelligence assists a person. He acts as a kind of body navigator. His task is to clearly represent the area of the operation and show what cannot be found in a standard CT scan.

"The Sechenov.AI nephro system allows us in most cases to perform kidney preservation in a tumor. To do this for the surgeon as comfortable as possible, with good visualization of the vessels that feed the tumor, and to achieve maximum oncological results," explained Evgeny Shpot, oncologist-urologist, deputy director for research at the Institute of Urology and Human Reproductive Health of Sechenov University.

In the future, the developers plan to integrate the technology into other areas of oncology where jewelry accuracy is required: operations on the liver, lungs, pancreas. This will maximize the preservation of healthy tissues and increase the patient's chances of a full life.